Insight Molecular Diagnostics Inc.

NASDAQ:IMDX

Medical - Diagnostics & Research

Healthcare
$1.59 +2.44%

+$0.13 today

Market cap
$52.08M
Beta
1.79
P/E (TTM)
-3.9
EPS (TTM)
-$1.39
52W Low $2.33High $8.51

Volume 0.64M

Average 0.38M

Cash Flow

Check whether earnings turn into cash.

Operating Cash Flow

-$22.18M

FY 2025 · Annual

Investing Cash Flow

-$3.19M

FY 2025 · Annual

Financing Cash Flow

$28.07M

FY 2025 · Annual

+37.4% YoY

Cash Flow Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Net Income(64.1M)(72.9M)(27.78M)(60.66M)(50.22M)
Depreciation & Amortization4.21M5.22M1.68M1.56M2.2M
Deferred Income Tax(9.26M)0000
Stock-Based Compensation6.84M10.04M6.57M1.91M2.22M
Change in Working Capital149K(1.94M)(3.97M)(1.32M)2.73M
Accounts Receivables(1.23M)(575K)109K(1.13M)485K
Inventory000(410K)(36K)
Accounts Payables(1.35M)297K(4.76M)967K2.65M
Other Working Capital2.73M(1.66M)677K(749K)(368K)
Other Non-Cash Items26.22M14.01M174K37.79M20.9M
Operating Cash Flow(35.94M)(45.57M)(23.33M)(20.71M)(22.18M)
Capital Expenditures(2.25M)(4.34M)(281K)(516K)(3.19M)
Acquisitions (Net)(11.71M)0000
Purchases of Investments00000
Sales of Investments00367K00
Other Investing Activities00(1.02M)4K0
Investing Cash Flow(13.96M)(4.34M)(932K)(512K)(3.19M)
Debt Repayment(1.53M)(1.43M)(117K)(201K)(510K)
Common Stock Issued77.99M32.84M13.85M27.81M28.66M
Common Stock Repurchased(239K)0000
Dividends Paid00000
Other Financing Activities2.15M(483K)(427K)(1.8M)(74K)
Financing Cash Flow78.36M35.81M12.19M20.43M28.07M
Effect of Forex Changes0000973K
Net Change in Cash28.46M(14.1M)(12.07M)(796K)3.68M
Free Cash Flow(38.19M)(49.91M)(23.61M)(21.23M)(25.37M)

Free Cash Flow

Net Income to FCF bridge

FY2025

= Net Income-$50.2M
+ D&A$2.2M
+ Stock-Based Comp$2.2M
+ Deferred Tax$0
+ Working Capital$2.7M
+ Other Non-Cash$20.9M
= Operating Cash Flow-$22.2M
- Capex-$3.2M
= Free Cash Flow-$25.4M

Analysis

FY2025 free cash flow is -$25.4M. FCF conversion is 50.5% of net income. Operating cash flow was -$22.2M, with capex of -$3.2M. The largest bridge item is Other Non-Cash at $20.9M.

Recent Filings

Recent regulatory filings

FilingDescriptionDate
8-KCurrent reportSep 21, 2026
10-QQuarterly reportAug 10, 2026
8-KCurrent reportAug 10, 2026
S-8S-8 filingJul 24, 2026
4Statement of changes in beneficial ownershipJul 6, 2026

Does IMDX generate free cash flow?

Insight Molecular Diagnostics Inc. (IMDX) generated -$25.37M of free cash flow in fiscal 2025.

How much operating cash flow does IMDX produce?

Operating cash flow was -$22.18M, before capital expenditures of $3.19M.